Everolimus versus alpelisib in higher level hormones receptor-positive breast that is HER2-negative focusing on different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications Abstract Background The PI3K/AKT/mTORC1 axis is implicated in hormone receptor-positive HER2-negative metastatic breast cancer (HR+ HER2в€’ … Lire la suite de Everolimus versus alpelisib in higher level hormones receptor-positive breast that is HER2-negative focusing on different nodes of the PI3K/AKT/mTORC1 pathway with different clinical implications